FREE CASH FLOW ON AN ADJUSTED BASIS $ (1) Adjustments for 2019 interest payments to reflect the Company's current capital structure by assuming that the sale of Arysta LifeScience Inc. (the “Arysta Sale”) had closed and its new credit agreement had been in place on January 1, 2019.